DETAILED NOTES ON BI8622

Detailed Notes on BI8622

OMEPRAZOLE: There have been no improvements while in the pharmacokinetic parameters of either cerivastatin or its significant active metabolites, or of omeprazole in healthy youthful males supplied solitary 0.3 mg oral doses of cerivastatin by itself or over the fifth working day of a five-working day omeprazole 20 mg daily pre-treatment.Rhabdomyol

read more